| scholarly article | Q13442814 |
| review article | Q7318358 |
| P6179 | Dimensions Publication ID | 1006902368 |
| P356 | DOI | 10.1007/S11926-008-0063-0 |
| P698 | PubMed publication ID | 18817644 |
| P2093 | author name string | Mary Chester M Wasko | |
| P2860 | cites work | Differences in atherosclerotic coronary heart disease between subjects with and without rheumatoid arthritis. | Q51761535 |
| Accelerated atherosclerosis in pre-menopausal female patients with rheumatoid arthritis. | Q51787678 | ||
| Common carotid intima-media thickness and von Willebrand factor serum levels in rheumatoid arthritis female patients without cardiovascular risk factors. | Q51801169 | ||
| TNF-alpha blockade induces a reversible but transient effect on endothelial dysfunction in patients with long-standing severe rheumatoid arthritis. | Q53511273 | ||
| Effects of high-dose atorvastatin on antiinflammatory properties of high density lipoprotein in patients with rheumatoid arthritis: a pilot study. | Q53548272 | ||
| Insulin resistance is an independent risk factor for atherosclerosis in rheumatoid arthritis | Q61628540 | ||
| HLA-DRB1 status affects endothelial function in treated patients with rheumatoid arthritis | Q61971712 | ||
| Antiphospholipid antibodies as a possible risk factor for atherosclerosis in patients with rheumatoid arthritis | Q79173049 | ||
| Acceleration of atherosclerosis during the course of rheumatoid arthritis | Q79348208 | ||
| Role of insulin resistance in increased frequency of atherosclerosis detected by carotid ultrasonography in rheumatoid arthritis | Q79402376 | ||
| Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis | Q79698753 | ||
| Independent association of increased trunk fat with increased arterial stiffening in postmenopausal patients with rheumatoid arthritis | Q79784944 | ||
| Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study | Q79850163 | ||
| Increased augmentation index in rheumatoid arthritis and its relationship to coronary artery atherosclerosis | Q80124180 | ||
| Thickened carotid artery intima-media in rheumatoid arthritis is associated with elevated anticardiolipin antibodies | Q80171473 | ||
| Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy | Q80213278 | ||
| Effect of anti-TNFalpha treatment on circulating endothelial progenitor cells (EPCs) in rheumatoid arthritis | Q80234116 | ||
| Comparison of energy expenditure from lifestyle physical activities between patients with rheumatoid arthritis and healthy controls | Q80244009 | ||
| Impaired coronary microvascular function and increased intima-media thickness in rheumatoid arthritis | Q80422098 | ||
| Does tumor necrosis factor alpha inhibition promote or prevent heart failure in patients with rheumatoid arthritis? | Q80800883 | ||
| Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis | Q80808131 | ||
| Ezetimibe and simvastatin reduce inflammation, disease activity, and aortic stiffness and improve endothelial function in rheumatoid arthritis | Q80843926 | ||
| Effects of selective and non-selective cyclo-oxygenase inhibition on endothelial function in patients with rheumatoid arthritis | Q80973662 | ||
| Ethnicity may be a reason for lipid changes and high Lp(a) levels in rheumatoid arthritis | Q83299924 | ||
| Fluvastatin reverses endothelial dysfunction and increased vascular oxidative stress in rat adjuvant-induced arthritis | Q28576951 | ||
| Association of the HLA-DRB1 gene with premature death, particularly from cardiovascular disease, in patients with rheumatoid arthritis and inflammatory polyarthritis | Q34401259 | ||
| Hydroxychloroquine and risk of diabetes in patients with rheumatoid arthritis | Q34648366 | ||
| Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment--a prospective, controlled study | Q34897630 | ||
| Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study | Q35605663 | ||
| Utility of the Framingham risk score to predict the presence of coronary atherosclerosis in patients with rheumatoid arthritis | Q35630128 | ||
| Endothelial dysfunction in patients with rheumatoid arthritis is associated with a reduced number and impaired function of endothelial progenitor cells | Q35636813 | ||
| Severe extra-articular disease manifestations are associated with an increased risk of first ever cardiovascular events in patients with rheumatoid arthritis | Q35638369 | ||
| Increased incidence of and impaired prognosis after acute myocardial infarction among patients with seropositive rheumatoid arthritis | Q35638708 | ||
| Patients with early rheumatoid arthritis exhibit elevated autoantibody titers against mildly oxidized low-density lipoprotein and exhibit decreased activity of the lipoprotein-associated phospholipase A2. | Q35769101 | ||
| Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritis | Q36204149 | ||
| Serum osteoprotegerin is increased and independently associated with coronary-artery atherosclerosis in patients with rheumatoid arthritis | Q36326701 | ||
| Atherosclerotic disease is increased in recent-onset rheumatoid arthritis: a critical role for inflammation | Q36465464 | ||
| Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register | Q36732112 | ||
| The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: roles of inflammation and dyslipidemia | Q36791429 | ||
| C-reactive protein and coronary artery calcium in asymptomatic women with systemic lupus erythematosus or rheumatoid arthritis | Q36928407 | ||
| Abnormal body composition phenotypes in older rheumatoid arthritis patients: association with disease characteristics and pharmacotherapies | Q37163337 | ||
| Inflammation-associated insulin resistance: differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms | Q37371379 | ||
| Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis | Q38465160 | ||
| Anti-tumour necrosis factor-alpha therapy over conventional therapy improves endothelial function in adults with rheumatoid arthritis. | Q40312662 | ||
| Effects of infliximab treatment on insulin resistance in patients with rheumatoid arthritis and ankylosing spondylitis | Q41951968 | ||
| Angiotensin-converting enzyme inhibition improves vascular function in rheumatoid arthritis | Q42165744 | ||
| Effects of anti-TNF-alpha treatment on lipid profile in patients with active rheumatoid arthritis | Q42498499 | ||
| HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis | Q42610707 | ||
| Stress activation of cellular markers of inflammation in rheumatoid arthritis: protective effects of tumor necrosis factor alpha antagonists | Q43678752 | ||
| Antioxidants and other novel cardiovascular risk factors in subjects with rheumatoid arthritis in a large population sample. | Q44883137 | ||
| Metabolic syndrome and subclinical atherosclerosis in rheumatoid arthritis | Q44951945 | ||
| Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients? | Q45235877 | ||
| Cardiovascular outcomes in male veterans with rheumatoid arthritis. | Q45331961 | ||
| Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis | Q46222728 | ||
| Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity. | Q46802505 | ||
| Increased arterial stiffness and indication of endothelial dysfunction in long-standing rheumatoid arthritis | Q46812634 | ||
| Long-term exposure to medium-dose glucocorticoid therapy associates with hypertension in patients with rheumatoid arthritis. | Q46852341 | ||
| Preclinical carotid atherosclerosis in patients with rheumatoid arthritis | Q46954458 | ||
| Anti-tumor necrosis factor therapy increases serum adiponectin levels with the improvement of endothelial dysfunction in patients with rheumatoid arthritis | Q46956048 | ||
| Infliximab but not methotrexate induces extra-high levels of VLDL-triglyceride in patients with rheumatoid arthritis. | Q51464070 | ||
| P433 | issue | 5 | |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| cardiovascular disease | Q389735 | ||
| P304 | page(s) | 390-397 | |
| P577 | publication date | 2008-10-01 | |
| P1433 | published in | Current Rheumatology Reports | Q23930052 |
| P1476 | title | Rheumatoid arthritis and cardiovascular disease | |
| P478 | volume | 10 |
| Q37331767 | Aspirin use in rheumatoid arthritis patients with increased risk of cardiovascular disease |
| Q33650548 | Association between use of disease-modifying antirheumatic drugs and diabetes in patients with ankylosing spondylitis, rheumatoid arthritis, or psoriasis/psoriatic arthritis: a nationwide, population-based cohort study of 84,989 patients |
| Q37883018 | Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE. |
| Q53653844 | Glucocorticoid use is associated with increase in HDL and no change in other lipids in rheumatoid arthritis patients. |
| Q36233048 | Is urate crystal precipitation a predictor of cardiovascular risk in hyperuricemic patients? A Danish cohort study |
| Q43450932 | Patterns of preventive health services in rheumatoid arthritis patients compared to a primary care patient population |
Search more.